Trajan Group Holdings Limited reported that FY26 was a year of two halves, with materially improved operating performance in the second half driving momentum into FY27 despite a weak first quarter and adverse foreign exchange movements from Australian dollar appreciation. For FY26, group revenue was $161.4 million, down 3.1% on the prior comparable period, and normalised EBITDA was $13.2 million, down 14.7%, while H2 normalised EBITDA rose 61.8% to $8.1 million from $5.0 million in H1 and gross margin improved to 40.6% from 37.4%, or about 41.2% on an FX-adjusted basis. The company said FX reduced H2 results by about $5.0 million in revenue and $2.4 million in normalised EBITDA, and on a currency-adjusted basis H2 normalised EBITDA would have been $10.5 million. Operational improvement was supported by Project Neptune, reduced corporate services headcount, footprint rationalisation, automation, manufacturing transfer to Malaysia and ERP rollout completion, while capital equipment remained affected by weaker North American funding conditions, global food market softness and the discontinuation of Certus revenue. Capex fell to $3.4 million from $4.1 million in FY25 and cash remained stable at $12.6 million. Looking to FY27, Trajan expects mid-single digit organic revenue growth and double-digit normalised EBITDA growth, with priorities focused on cost efficiency, margin expansion, working capital optimisation, debt reduction and disciplined capital allocation.
Key Points
H2 FY26 operating performance improved materially over H1, with stronger margins and earnings recovery.
FY26 revenue was $161.4 million, down 3.1% on the prior comparable period.
FY26 normalised EBITDA was $13.2 million, down 14.7% on the prior comparable period.
H2 FY26 normalised EBITDA was $8.1 million, up 61.8% from $5.0 million in H1.
H2 proforma gross margin improved to 40.6% from 37.4% in H1.
Australian dollar appreciation in H2 reduced reported earnings, with about $5.0 million revenue and $2.4 million normalised EBITDA impact.
On a currency-adjusted basis, H2 normalised EBITDA would have been $10.5 million.
Project Neptune and corporate services headcount reductions each contributed about $1.2 million uplift in H2.
Capital equipment was affected by weak North American funding conditions, food market softness and the discontinuation of Certus revenue.
Capex decreased to $3.4 million in FY26 from $4.1 million in FY25, with cash stable at $12.6 million.
Trajan expects mid-single digit organic revenue growth and double-digit normalised EBITDA growth in FY27.
FY27 priorities are cost efficiency, margin expansion and stronger capital management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.